ONEMEDNET CORPORATION Operating Cash Flow
ONEMEDNET CORPORATION (ONMD) reported Operating Cash Flow of -$3.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- ONEMEDNET CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.88M.
- ONEMEDNET CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.54M.
- ONEMEDNET CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.71M.
- ONEMEDNET CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.75M.
- ONEMEDNET CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was -$4.79M.
- ONEMEDNET CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was -$4.70M.
| Period end | Net Cash Provided by (Used in) Operating Activities 2 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 5 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 11 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.88M derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | -$3.42M 10-Q · filed 2026-08-14 | -$5.13M derived: sum of 3 quarters · filed 2026-08-14 | -$6.88M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||
| 2026-03-31 | -$1.54M S-1/A · filed 2026-07-08 | -$3.25M derived: sum of 2 quarters · filed 2026-07-08 | -$5.00M derived: sum of 3 quarters · filed 2026-07-08 | -$7.19M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||
| 2025-12-31 | -$1.71M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$3.46M derived: sum of 2 quarters · filed 2026-07-08 | -$5.65M derived: sum of 3 quarters · filed 2026-08-14 | -$7.50M S-1/A · filed 2026-07-08 | |||||||||
| 2025-09-30 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.94M derived: sum of 2 quarters · filed 2026-08-14 | -$5.79M 10-Q · filed 2025-11-14 | -$7.79M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||
| 2025-06-30 | -$2.19M derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | -$4.04M 10-Q · filed 2026-08-14 | -$4.23M 10-Q · filed 2025-08-13 | -$6.04M derived: sum of 3 quarters · filed 2026-08-14 | -$7.94M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-03-31 | -$1.85M S-1/A · filed 2026-07-08 | -$1.95M 10-Q · filed 2025-05-14 | -$3.85M derived: sum of 2 quarters · filed 2026-07-08 | -$5.75M derived: sum of 3 quarters · filed 2026-07-08 | -$7.26M derived: sum of 4 quarters · filed 2026-07-08 | ||||||||
| 2024-12-31 | -$2.00M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$3.90M derived: sum of 2 quarters · filed 2026-07-08 | -$5.41M derived: sum of 3 quarters · filed 2026-07-08 | -$6.95M S-1/A · filed 2026-07-08 | -$6.98M 10-K · filed 2025-04-15 | ||||||||
| 2024-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.41M derived: sum of 2 quarters · filed 2025-11-14 | -$4.96M 10-Q · filed 2025-11-14 | -$6.68M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||
| 2024-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.05M 10-Q · filed 2025-08-13 | -$4.78M derived: sum of 3 quarters · filed 2025-08-13 | -$5.88M derived: sum of 4 quarters · filed 2025-08-13 | |||||||||
| 2024-03-31 | -$1.55M 10-Q · filed 2025-05-14 | -$3.27M derived: sum of 2 quarters · filed 2025-05-14 | -$4.37M derived: sum of 3 quarters · filed 2025-05-14 | -$5.34M derived: sum of 4 quarters · filed 2025-05-14 | |||||||||
| 2023-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$2.83M derived: sum of 2 quarters · filed 2025-04-15 | -$3.79M derived: sum of 3 quarters · filed 2025-04-15 | -$4.79M 10-K · filed 2025-04-15 | $8.22M 10-K · filed 2024-04-09 | ||||||||
| 2023-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | -$2.06M derived: sum of 2 quarters · filed 2024-12-17 | -$3.07M 10-Q · filed 2024-12-17 | -$4.71M 10-Q · filed 2023-11-20 | -$4.41M derived: sum of 4 quarters · filed 2024-12-17 | ||||||||
| 2023-06-30 | -$964.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-11 | -$1.97M 10-Q · filed 2024-12-11 | -$646.58K 10-Q · filed 2023-08-14 | -$3.31M derived: sum of 3 quarters · filed 2024-12-11 | -$6.22M derived: sum of 4 quarters · filed 2024-12-11 | ||||||||
| 2023-03-31 | -$1.00M 10-Q · filed 2024-12-05 | -$52.46K 10-Q · filed 2023-05-19 | -$2.35M derived: sum of 2 quarters · filed 2024-12-05 | -$5.26M derived: sum of 3 quarters · filed 2024-12-05 | -$5.41M derived: sum of 4 quarters · filed 2024-12-05 | ||||||||
| 2022-12-31 | -$1.35M derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | -$4.26M derived: sum of 2 quarters · filed 2024-11-22 | -$4.41M derived: sum of 3 quarters · filed 2024-11-22 | -$4.70M 10-K/A · filed 2024-11-05 | -$940.46K 10-K · filed 2023-03-31 | ||||||||
| 2022-09-30 | -$2.91M derived: 8-K/A 9 month − 10-Q 6 month · filed 2024-11-22 | -$3.06M derived: sum of 2 quarters · filed 2024-11-22 | -$3.36M 8-K/A · filed 2024-11-22 | -$796.54K 10-Q · filed 2022-11-18 | |||||||||
| 2022-06-30 | -$151.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$445.67K 10-Q · filed 2023-08-14 | |||||||||||
| 2022-03-31 | -$294.02K 10-Q · filed 2023-05-19 | ||||||||||||
| 2021-12-31 | -$378.49K 10-K · filed 2023-03-31 | ||||||||||||
| 2021-09-30 | -$297.93K 10-Q · filed 2022-11-18 | ||||||||||||
| 2021-06-30 | -$29.53K 10-Q · filed 2022-08-15 | -$654.59K 10-Q · filed 2021-08-16 | |||||||||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |